|Articles|August 14, 2008
Drug Designed to Fight MS Could Target Viral Infections
Advertisement
Reuters is reporting today that a new drug, FTY720, also called fingolimod, that Novartis AG is testing in individuals with multiple sclerosis could also tackle some viral infections, including perhaps including meningitis and perhaps even the AIDS virus. For the complete article,
Source: Reuters
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Infection Control Today
1
Can You Prevent What You Cannot See? Exploring Real-Time Microbial Visualization for Infection Prevention and Environmental Services
2
An Untapped Opportunity for Infection Prevention: Health Care Disinfectant Wipes That Help Deliver on Performance and Sustainability Goals
3
CLABSIs: A Preventable Threat Is Still Costing Hospitals and Patients
4
Crisis, Innovation, and Professionalism: Reflecting on 30 Years of Progress in Medical Device Reprocessing
5